Renovion renovion.com


Public lists: Pharma Startups (4732)

Renovion is a pre-clinical stage pharmaceutical company with a therapy for chronic inflammatory airway diseases. The company's goal is to be the first drug ever approved for patients that have received a bilateral lung transplant.

Renovion is a pre-clinical stage pharmaceutical company with a therapy for chronic inflammatory airway diseases. The company's goal is to be the first drug ever approved for patients that have received a bilateral lung transplant.

Company (Alive / Active)

Phone: 919-314-8340

Fax:

112 South Duke Street

Durham, 27701
North Carolina, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Renovion $2.2M May 15, 2018

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Renovion Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 1 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)